Close Menu
    What's Hot

    UK Pension Risk Transfer Market Set to Hit £70bn in 2026

    February 10, 2026

    Deloitte UK Pension Schemes Completes Bulk Purchase Annuity Buy-In With Standard Life

    February 10, 2026

    Trustee of Vistry’s Final Salary Pension Schemes Completes Bulk Purchase Annuity Buy-In With PIC

    February 10, 2026
    X (Twitter) LinkedIn
    Longevity & Mortality Investor
    • Home
    • Coverage
      1. Life Insurance Capital Solutions
      2. Life Insurance
      3. Longevity and Mortality Risk Transfer
      4. Mortality
      5. Secondary Life Markets
      6. View All

      Reporting Change to Provide Regulators With More Transparency into US/Offshore Asset-Intensive Life Reinsurance Treaties

      January 28, 2026

      Capital Markets Investors Could Be About to Get a Slice of UK Life Insurance Risk

      November 26, 2025

      Tailwinds and Structural Strength Support Sustainable — If Moderating — US Life & Annuity Market Growth

      November 12, 2025

      US Annuity Sales Set Yet Another Quarterly Sales Record in Third Quarter of 2025

      October 30, 2025

      10 Areas To Watch for AI Innovation in Life and Health Underwriting and Claims

      January 28, 2026

      Lewis & Ellis and Griffith, Ballard & Company Expand Life Insurance Capabilities Through Strategic Partnership

      January 21, 2026

      Stability Continues in US Life Insurer Ownership and Solvency Metrics

      January 14, 2026

      Third Quarter Sets New US Annuity Sales Record

      December 10, 2025

      UK Pension Risk Transfer Market Set to Hit £70bn in 2026

      February 10, 2026

      Deloitte UK Pension Schemes Completes Bulk Purchase Annuity Buy-In With Standard Life

      February 10, 2026

      Trustee of Vistry’s Final Salary Pension Schemes Completes Bulk Purchase Annuity Buy-In With PIC

      February 10, 2026

      The Argent Group Europe Pension Scheme Secures Full Scheme Bulk Purchase Annuity Buy-In With Just Group

      February 9, 2026

      CMI Model Changes and Weight-Loss Drug Popularity Point to Changed Mortality Picture

      January 14, 2026

      Still Hot and Bothered?

      December 22, 2025

      Decoding Progress: The Evolution of Life Expectancy for Cancer Patients

      November 26, 2025

      Q&A: James Hadley, Senior Consultant, Barnett Waddingham

      November 26, 2025

      UK Equity Release Market Sees Double-Digit Growth in 2025

      January 28, 2026

      Equity Release Missing From Retirement Planning Conversations

      January 22, 2026

      Equity Release Council Promotes Kelly Melville-Kelly to Deputy CEO

      January 22, 2026

      AIR Asset Management’s Taylor Garvey Joins LISA Board, Promoted to Managing Director

      January 19, 2026

      UK Pension Risk Transfer Market Set to Hit £70bn in 2026

      February 10, 2026

      Deloitte UK Pension Schemes Completes Bulk Purchase Annuity Buy-In With Standard Life

      February 10, 2026

      Trustee of Vistry’s Final Salary Pension Schemes Completes Bulk Purchase Annuity Buy-In With PIC

      February 10, 2026

      The Argent Group Europe Pension Scheme Secures Full Scheme Bulk Purchase Annuity Buy-In With Just Group

      February 9, 2026
    • Events
    • Latest Issues

      Editor’s Letter – Volume 2, Issue 1, January 2026

      January 14, 2026

      Editor’s Letter – Volume 1, Issue 3, December 2025

      December 10, 2025

      Editor’s Letter – Volume 1, Issue 2, November 2025

      November 12, 2025

      Editor’s Letter – Volume 1, Issue 1, October 2025

      October 8, 2025

      Editor’s Letter – Volume 4, Issue 9, September 2025

      September 10, 2025
    • Contact Us
    Newsletter
    Longevity & Mortality Investor

    Caveat Emptor: Life Settlements and the Natural Person Exemption From Licensure

    Secondary Life Markets February 8, 2023By James Maxson
    Litigation
    Share
    Twitter LinkedIn Email

    Interest in the life settlement asset class, the purchase of an unwanted and unneeded life insurance policy for a lump sum payment, has continued to grow steadily over the course of the last two decades because of potential double digit returns uncorrelated to the capital markets. The foundation for investors’ confidence in the asset class is that the policies purchased are legally originated and will not be subject to challenge by the policies’ former owners or beneficiaries. A recent decision from a federal court in Texas calls into question the viability of an often-used exemption from licensure and emphasizes how important it is that investors carefully diligence the policies they purchase, or risk losing their entire investment.

    Stakeholders and investors in the life settlements market know that to purchase a life insurance policy from a non-terminally ill owner, it is necessary to have a “provider’s” license in 43 of the 50 states. These licenses are time consuming and expensive to obtain, and their maintenance entails significant on-going compliance obligations. Thus, it is no surprise that providers who have invested years and tens of thousands of dollars in time and money into procuring and maintaining these licenses take umbrage with individuals and companies who regularly rely on the so-called “natural person” exemption from licensure to purchase policies.

    This exemption, which is found in both the National Association of Insurance Commissioners’ (“NAIC”) and National Council of Insurance Legislators’ (“NCOIL”) model acts, typically reads along the lines of the following:

    “Settlement provider” does not include: A natural person who enters into or effectuates no more than one agreement in a calendar year for the transfer of life insurance policies.

    According to the Proceedings of the NAIC, when it adopted its model settlement act in 1993, the intent of including the “natural person” exemption was “to exclude from the Act a friend or family member of the policyholder who wanted to enter into an agreement with a [policy owner][,]”  because, “it would create a hardship to subject family and friends to the model act.” 1993 Proc. 3rd Quarter 439.  Hence, the intent of the NAIC in adopting the exemption was clear – to exclude a person with a close relationship to a policy owner from the burdensome obligations associated with provider licensure.

    In contravention of the explicit intent of the NAIC, some participants in the life settlements industry have taken this exemption for use by a friend or family member and turned it into a business model, allowing them to act as a provider without having to shoulder the burden and expense of obtaining providers’ licenses. This is the fact pattern that the court confronted recently in Consolidated Wealth Management, LLC v. Short, 414 F.Supp.3d 1011 (S.D. Tex. 2019).

    In January 2014, James Short, a resident of West Virginia, entered into a Senior Facilitation Agreement (“SFA”) with an individual employee of Montage Financial Group (“Montage”). Montage played no role in the transaction with Mr. Short and was not a party to the SFA. Under the terms of the SFA, Mr. Short agreed to assign his interest in the policy for a payment of $25,016. Three days after entering the SFA with Mr. Short, the individual assigned his entire interest in the policy to Consolidated Wealth Management (“CWM”) for a payment of $37,700.

    On June 22, 2018, Mr. Short passed away. Mrs. Short thereafter filed a claim for the death benefit under the policy, and CWM made a competing claim. As a result, the carrier filed an interpleader action.

    The parties’ arguments were straightforward. Mrs. Short contended that the sale of her husband’s policy violated West Virginia’s viatical settlement law, and was, therefore, unlawful and void.  Whereas, CWM argued that under the “natural person” exemption in West Virginia’s law, the individual who purchased the policy was not a “viatical settlement provider” when he entered into the SFA and therefore the SFA is not a “viatical settlement contract” under West Virginia law.

    Even though the court found that the individual who purchased Mr. Short’s policy had only entered into a single settlement contract in the pertinent year, it nevertheless ruled in favor of Mrs. Short.  The court’s reasoning was founded on a common-sense interpretation of the language of the statute.

    It was the uncontroverted testimony of the individual that he, through Montage, had been involved in approximately 75 viatical settlements in 2014 and a “bit less” in 2013. The court noted that the “statute excepts from coverage persons who neither enter into more than one viatical settlement contract nor effectuate more than one such contract in a year. A person must meet both conditions to be excluded from the Act’s scope.” 414 F.Supp.3d at 1018-19. The court rejected the argument that the only operative language was “enters into” and ruled that the individual had clearly “effectuated” far more than one contract in his work at Montage.

     The court also rejected CWM’s argument that the exception applies to persons who regularly effectuate settlement contracts so long as they contract with only a single West Virginia resident in a calendar year, finding that the “exception only covers ‘an individual who enters into or effectuates no more than one viatical settlement contract in a calendar year,’ without regard to the viator’s state of residence.”  Id.

    As a result, the court effectively unwound the sale transaction and awarded the entire death benefit to Mrs. Short. 

    While this appears to be a case of first impression, it is possible other courts faced with similar facts will reach the same conclusion. Therefore, investors in the life settlements asset class would be wise to deal only with licensed life settlement providers, and not individuals who improperly utilize the natural person exemption from licensing to purchase policies.

    Finally, it is worth noting that state insurance departments currently do not appear to be aware of the extent to which this exemption is utilized by individuals to skirt the licensing rules or is used by otherwise licensed providers to purchase policies in states where they are not licensed. If state regulators do become aware of the extensive use, and arguable abuse, of the exemption it is likely regulatory consequences will follow.

    James W. Maxson is a Founding Partner at Edwards Maxson Mago & Macaulay, LLP


    Any views expressed in this article are those of the author(s) and do not necessarily reflect the views of Life Risk News or its publisher, the European Life Settlement Association.

    Commentary Life Settlements Longevity Risk Volume 2 Issue 2 - February 2023
    Share. Twitter LinkedIn Email

    Related Posts

    UK Pension Risk Transfer Market Set to Hit £70bn in 2026

    February 10, 2026By LMI Newsdesk

    Deloitte UK Pension Schemes Completes Bulk Purchase Annuity Buy-In With Standard Life

    February 10, 2026By LMI Newsdesk

    Trustee of Vistry’s Final Salary Pension Schemes Completes Bulk Purchase Annuity Buy-In With PIC

    February 10, 2026By LMI Newsdesk

    The Argent Group Europe Pension Scheme Secures Full Scheme Bulk Purchase Annuity Buy-In With Just Group

    February 9, 2026By LMI Newsdesk
    Latest Issue

    Busy December in PHL Variable Life Insurance Company Saga but Is the End Now in Sight?

    January 14, 2026

    Will 2026 Be the Year That the US Agency-Backed Reverse Mortgage Market Finally Gets Its Well-Overdue Reform?

    January 14, 2026

    CMI Model Changes and Weight-Loss Drug Popularity Point to Changed Mortality Picture

    January 14, 2026

    Stability Continues in US Life Insurer Ownership and Solvency Metrics

    January 14, 2026
    Ad

    Where Longevity and Mortality Meet the Markets
    ISSN 2978-5219

    X (Twitter) LinkedIn
    Coverage
    • Life Insurance Capital Solutions
    • Life Insurance
    • Longevity and Mortality Risk Transfer
    • Mortality Risk
    • Secondary Life Markets
    More Info
    • Home
    • About Us
    • Contact Us
    • Guest Articles
    • Submit Story Idea
    Our Newsletter
    Get the latest industry news, commentary and events from the Longevity & Mortality Investor directly into your inbox. Why not sign up today?

    © 2026 Longevity & Mortality Investor. Website by Kavells.
    • Sitemap
    • Privacy Policy
    • Copyright Notice
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.